CDH2 and central nervous system cancer: For instance, FRK inhibits cell proliferation, migration and invasion in glioma cells by promoting N-cadherin/β-catenin complex formation [10], inhibiting cyclin D1 nuclear accumulation [11] and regulating JNK/c-Jun signaling [12].